Sage Therapeutics, Inc

(NASDAQ:SAGE)

Latest On Sage Therapeutics, Inc (SAGE):

Date/Time Type Description Signal Details
2023-05-09 17:58 ESTNewsSage Therapeutics: Mid-2023 Data Readout And Possible FDA Approval Make This A Must WatchN/A
2023-05-03 02:24 ESTNewsSage Therapeutics, Inc. (SAGE) Q1 2023 Earnings Call TranscriptN/A
2023-05-02 14:08 ESTNewsSage Therapeutics GAAP EPS of -$2.46 beats by $0.06, revenue of $3.3M beats by $1.02MN/A
2023-05-01 13:35 ESTNewsSage Therapeutics Q1 2023 Earnings PreviewN/A
2023-03-13 18:37 ESTNewsSage upgraded to outperform at RBC on greater confidence in zuranolone approvalN/A
2023-03-08 15:36 ESTNewsFDA to not hold panel meeting for Biogen, Sage's depression therapy zuranoloneN/A
2023-02-22 17:22 ESTNewsSage's therapy for Huntington's disease gets orphan drug status in EUN/A
2023-02-21 15:46 ESTNewsSage Therapeutics Looking To FDA Approval Of ZuranoloneN/A
2023-02-16 18:12 ESTNewsSage Therapeutics mixed Q4 earnings; initiates FY23 outlookN/A
2023-02-16 18:12 ESTNewsSage Therapeutics, Inc. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-16 18:12 ESTNewsSage Therapeutics, Inc. (SAGE) Q4 2022 Earnings Call TranscriptN/A
2023-02-06 08:46 ESTNewsBiogen, Sage win FDA priority review for depression therapyN/A
2023-01-10 13:49 ESTNewsSage Therapeutics sees depression treatment zuranolone hitting the market as early as Q3N/A
2022-12-13 11:39 ESTNewsSage Therapeutics Could Be In For A Depressing FDA ReviewN/A
2022-12-10 15:56 ESTNewsSage Therapeutics: Zuranolone NDA Near-Term TailwindN/A
2022-12-07 00:56 ESTNewsSage, Biogen complete rolling filing with FDA for depression therapy zuranoloneN/A
2022-11-08 18:43 ESTNewsSage Therapeutics GAAP EPS of -$2.31 misses by $0.11, revenue of $1.74M beats by $0.08MN/A
2022-11-08 18:42 ESTNewsSage Therapeutics, Inc. (SAGE) Q3 2022 Earnings Call TranscriptN/A
2022-11-01 15:03 ESTNewsSage Therapeutics appoints Laura Gault as Chief Medical OfficerN/A
2022-08-02 20:37 ESTNewsSage Therapeutics GAAP EPS of -$2.13 beats by $0.02, revenue of $1.5M misses by $0.27MN/A
2022-08-02 20:37 ESTNewsSage Therapeutics, Inc. (SAGE) CEO Barry Greene on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-01 15:32 ESTNewsSage Therapeutics Q2 2022 Earnings PreviewN/A
2022-06-13 12:22 ESTNewsBiogen, Sage to submit a single marketing application for depression candidateN/A
2022-06-01 20:21 ESTNewsBiogen/Sage's zuranolone helps reduce postpartum depression symptoms, meets main goal of trialN/A
2022-05-03 20:09 ESTNewsSage Therapeutics GAAP EPS of -$2.07 misses by $0.04, revenue of $1.58M misses by $1.65MN/A
2022-05-03 20:09 ESTNewsSage Therapeutics, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-03 20:09 ESTNewsSage Therapeutics, Inc. (SAGE) CEO Barry Greene on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-03 01:57 ESTNewsSage Therapeutics Q1 2022 Earnings PreviewN/A
2022-05-02 08:38 ESTNewsSage, Biogen begin rolling submission with FDA for zuranolone to treat depressionN/A
2022-04-01 11:49 ESTNewsSage stock rises 15% as drug shows function/learning benefit in Alzheimer’s patients with dementiaN/A
2022-03-30 23:35 ESTNewsSage Therapeutics (SAGE) presents at 2022 Stifel CNS Days - SlideshowN/A
2022-03-24 23:14 ESTNewsSage Therapeutics: Well-Funded But Uninspiring DataN/A
2022-03-15 09:02 ESTNewsSage Therapeutics drug benefits cognitive function in phase 2 trial in Parkinson’sN/A
2022-03-01 12:26 ESTNewsSage Therapeutics, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-24 18:37 ESTNewsSage Therapeutics GAAP EPS of -$2.12 beats by $0.05, revenue of $1.6M misses by $0.17MN/A
2022-02-24 18:36 ESTNewsSage Therapeutics' (SAGE) CEO Barry Greene on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 01:32 ESTNewsSage Therapeutics Q4 2021 Earnings PreviewN/A
2022-02-17 03:14 ESTNewsSage, Biogen announce late-stage trial for depression therapy met key goalsN/A
2022-02-01 14:17 ESTNewsNew thematic psychedelic ETF hits the marketN/A
2022-01-13 04:09 ESTNewsSage Therapeutics (SAGE) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-04 02:08 ESTNewsSage Therapeutics: Biogen's Backing May See It ThroughN/A
2021-12-08 12:43 ESTNewsSage Therapeutics, Biogen reports new analyses from Landscape program of zuranolone in MDDN/A
2021-12-01 08:17 ESTNewsSage Therapeutics, Biogen report positive zuranolone data in late-stage depression studyN/A
2021-11-02 22:49 ESTNewsSage Therapeutics EPS misses by $0.36, misses on revenueN/A
2021-11-02 22:49 ESTNewsSage Therapeutics posts Q3 earnings miss, pipeline updateN/A
2021-11-02 22:48 ESTNewsSage stock hits 52-week low as departure of medical chief follows earnings missN/A
2021-11-02 22:47 ESTNewsSAGE Therapeutics, Inc. (SAGE) CEO Barry Greene on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-02 22:47 ESTNewsSage Therapeutics, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-02 03:24 ESTNewsSage Therapeutics Q3 2021 Earnings PreviewN/A
2021-10-19 17:36 ESTNewsBiogen, Sage expect marketing application for depression therapy in H2 2022N/A

About Sage Therapeutics, Inc (SAGE):

Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, bipolar depression, and generalized anxiety disorders; and SAGE-324, a compound that is in Phase II clinical trial to treat essential tremors, as well as has completed Phase I clinical trial for epilepsy and Parkinson's diseases. In addition, its product pipeline comprises SAGE-718, an oxysterol-based positive allosteric modulator of the NMDA receptor, which has completed Phase I clinical trial for the treatment of depression, Huntington's disease, Alzheimer's disease, attention deficit hyperactivity disorder, schizophrenia, and neuropathic pain. Sage Therapeutics, Inc. has a strategic collaboration with Shionogi & Co., Ltd. for the development and commercialization of zuranolone in Japan, Taiwan, and South Korea; and a collaboration and license agreement with Biogen MA Inc. to jointly develop and commercialize SAGE-217 and SAGE-324 products. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

SAGE Quotes by TradingView

See Advanced Chart

General

  • Name Sage Therapeutics, Inc
  • Symbol SAGE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 298
  • Fiscal Year EndDecember
  • IPO Date2014-07-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.sagerx.com
View More

Valuation

  • Trailing PE 6.57
  • Price/Sales (Trailing 12 Mt.) 3.76
  • Price/Book (Most Recent Quarter) 2.23
  • Enterprise Value Revenue 2.28
  • Enterprise Value EBITDA 4.05
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$7.73
  • Next Year EPS Estimate -$6.01
  • Next Quarter EPS Estimate $0.75
  • Profit Margin 54%
  • Operating Margin 56%
  • Return on Assets 24%
  • Return on Equity 40%
  • Revenue 1.11 billion
  • Earnings Per Share $11.43
  • Revenue Per Share $21.43
  • Gross Profit 820.92 million
  • Quarterly Earnings Growth 56491.1%
View More

Highlights

  • Market Capitalization 4.38 billion
  • EBITDA 626.6 million
  • PE Ratio -1.25
  • PEG Ratio 0.74
  • Analyst Target Price $102.21
  • Book Value Per Share $35.54
View More

Share Statistics

  • Shares Outstanding 58.38 million
  • Shares Float 51.18 million
  • % Held by Insiders 161%
  • % Held by Institutions 93.8%
  • Shares Short 5.2 million
  • Shares Short Prior Month 5.1 million
  • Short Ratio 10.41
  • Short % of Float 12%
  • Short % of Shares Outstanding 9%
View More

Technicals

  • Beta 2.05
  • 52 Week High $98.39
  • 52 Week Low $25.25
  • 50 Day Moving Average 80.49
  • 200 Day Moving Average 74.68
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Sage Therapeutics, Inc (SAGE) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Sage Therapeutics, Inc (SAGE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$1.11 billion$18.19-$2.12959.26%
2020-09-302020-11-05$1.64 million-$2.04-$2.4717.25%
2020-06-302020-08-10$N/A-$2.08-$2.5919.67%
2020-03-312020-05-07$2.29 million-$2.44-$3.1722.99%
2019-12-312020-02-27$1.96 million-$3.25-$3.6310.53%
2019-09-302019-11-12$3.57 million-$3.48-$3.38-3.02%
2019-06-302019-08-06$873000-$3.28-$3.352.04%
2019-03-312019-05-02$465000-$3.37-$3.19-5.73%
2018-12-312019-02-19$273000-$3.38-$2.92-15.89%
2018-09-302018-11-06$-90000000-$2.63-$2.40-9.38%
2018-06-302018-08-07$90 million-$0.36-$1.8280.24%
2018-03-312018-05-03$N/A-$1.68-$1.817.31%
2017-12-312018-02-22$N/A-$1.75-$2.0113.1%
2017-09-302017-11-02$N/A-$1.97-$1.93-2.03%
2017-06-302017-08-03$N/A-$1.88-$1.63-15.05%
2017-03-312017-05-09$N/A-$1.52-$1.551.94%
2016-12-312017-02-23$N/A-$1.50-$1.17-27.79%
2016-09-302016-11-03$N/A-$1.15-$1.09-5.49%
2016-06-302016-08-09$N/A-$1.08-$1.01-7.16%
2016-03-312016-05-05$N/A-$0.97-$0.970%
2015-12-312016-02-24$N/A-$0.99-$0.94-5.34%
2015-09-302015-11-05$N/A-$0.84-$0.83-1.2%
2015-06-302015-08-12$N/A-$0.90-$0.68-32.35%
2015-03-312015-05-14$N/A-$0.66-$0.49-34.69%
2014-12-312015-02-27$N/A-$0.57-$0.43-32.56%
2014-09-302014-11-11$N/A-$0.50-$0.40-25%
2014-06-302014-08-14$N/A-$4.57-$1.23-271.54%

Sage Therapeutics, Inc (SAGE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Sage Therapeutics, Inc (SAGE) Chart:

Sage Therapeutics, Inc (SAGE) News:

Below you will find a list of latest news for Sage Therapeutics, Inc (SAGE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Sage Therapeutics, Inc (SAGE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-08-162.50CALL0 0946.68TRUE00
2024-08-1650CALL0 0264.56TRUE00
2024-08-167.52.62CALL1 4537232.05TRUE-0.33-0.11
2024-08-16100.85CALL260 100957.81TRUE-0.55-0.39
2024-08-1612.50.24CALL7 335683.21FALSE-0.01-0.04
2024-08-16150.08CALL3 112297.29FALSE0.030.6
2024-08-1617.50.25CALL0 690FALSE00
2024-08-16200.1CALL0 1580FALSE00
2024-08-1622.50.2CALL0 2660FALSE00
2024-08-16250.04CALL1 498170.66FALSE0.040
2024-08-1627.50.2CALL0 580FALSE00
2024-08-16300.15CALL0 380FALSE00
2024-08-1632.50.1CALL0 430FALSE00
2024-08-16350.05CALL0 5160FALSE00
2024-08-1637.51.9CALL0 30FALSE00
2024-08-16400.15CALL0 1100FALSE00
2024-08-162.50PUT0 00FALSE00
2024-08-1650.03PUT0 70FALSE00
2024-08-167.50.03PUT41 17481.53FALSE-0.12-0.8
2024-08-16100.5PUT118 130573.88FALSE-0.05-0.09
2024-08-1612.52.41PUT1 45465.85TRUE0.110.05
2024-08-16154.7PUT0 1437167.01TRUE00
2024-08-1617.54.9PUT0 17175.92TRUE00
2024-08-16207.2PUT0 33174.15TRUE00
2024-08-1622.511PUT0 3395.25TRUE00
2024-08-162514.4PUT0 314201.59TRUE00
2024-08-1627.517.25PUT0 0235.36TRUE00
2024-08-163011PUT0 2428.48TRUE00
2024-08-1632.50PUT0 0322.64TRUE00
2024-08-16350PUT0 0392.28TRUE00
2024-08-1637.50PUT0 0391.52TRUE00
2024-08-16400PUT0 0411.57TRUE00
2024-09-202.50CALL0 0275.18TRUE00
2024-09-2050CALL0 0255.92TRUE00
2024-09-207.50CALL0 089.48TRUE00
2024-09-20103.94CALL0 300TRUE00
2024-09-2012.50.43CALL4 064.36FALSE0.430
2024-09-20151.55CALL0 50FALSE00
2024-09-2017.50CALL0 00FALSE00
2024-09-20200.6CALL0 50FALSE00
2024-09-2022.50CALL0 00FALSE00
2024-09-202.50PUT0 00FALSE00
2024-09-2050PUT0 00FALSE00
2024-09-207.50.25PUT0 374.11FALSE00
2024-09-20100.82PUT120 3467.33FALSE-0.11-0.12
2024-09-2012.52.59PUT1 479.16TRUE2.590
2024-09-20153.3PUT0 5144.17TRUE00
2024-09-2017.55.75PUT0 1107.85TRUE00
2024-09-20200PUT0 0120.59TRUE00
2024-09-2022.50PUT0 0136.17TRUE00
2024-11-152.511.55CALL0 1475.19TRUE00
2024-11-1557.08CALL0 2598.98TRUE00
2024-11-157.54CALL0 669.59TRUE00
2024-11-15101.99CALL0 2163.18TRUE00
2024-11-1512.51.37CALL0 3477.33FALSE00
2024-11-15150.55CALL0 1210FALSE00
2024-11-1517.50.3CALL0 390FALSE00
2024-11-15200.25CALL0 1990FALSE00
2024-11-1522.50.19CALL0 6100FALSE00
2024-11-15250.29CALL0 240FALSE00
2024-11-1527.50.5CALL0 40FALSE00
2024-11-15300CALL0 00FALSE00
2024-11-1532.50.64CALL0 100FALSE00
2024-11-152.50PUT0 00FALSE00
2024-11-1550.19PUT0 40FALSE00
2024-11-157.50.8PUT1 0102.11FALSE0.80
2024-11-15101.5PUT1 7280.33FALSE0.30.25
2024-11-1512.53.2PUT0 3171.52TRUE00
2024-11-15154.4PUT0 781.12TRUE00
2024-11-1517.53PUT0 277.4TRUE00
2024-11-15200PUT0 0133.13TRUE00
2024-11-1522.50PUT0 0103TRUE00
2024-11-152513.4PUT0 1113.32TRUE00
2024-11-1527.50PUT0 0167.77TRUE00
2024-11-15300PUT0 0150.3TRUE00
2024-11-1532.50PUT0 0142.99TRUE00
2025-01-172.50CALL0 0262.55TRUE00
2025-01-1756.85CALL0 592.58TRUE00
2025-01-177.50CALL0 077.29TRUE00
2025-01-17102.65CALL0 5599.44TRUE00
2025-01-1712.51.51CALL97 6973.24FALSE1.510
2025-01-17150.95CALL5 20273.41FALSE-0.11-0.1
2025-01-1717.50.59CALL190 12473.02FALSE0.590
2025-01-17201.25CALL0 230FALSE00
2025-01-1722.50.8CALL0 1510FALSE00
2025-01-17250.25CALL0 3160FALSE00
2025-01-1727.50.25CALL0 510FALSE00
2025-01-17300.25CALL0 680FALSE00
2025-01-1732.50.25CALL0 2500FALSE00
2025-01-17350.15CALL0 530FALSE00
2025-01-1737.50.05CALL0 20490FALSE00
2025-01-17400.05CALL5 72684.74FALSE0.050
2025-01-172.50PUT0 00FALSE00
2025-01-1750PUT0 00FALSE00
2025-01-177.50.9PUT0 1274.89FALSE00
2025-01-17101.8PUT4 11076.91FALSE00
2025-01-1712.53.6PUT0 43379.53TRUE00
2025-01-17154.1PUT0 475.71TRUE00
2025-01-1717.56.39PUT0 5862.52TRUE00
2025-01-17208.61PUT0 1283.37TRUE00
2025-01-1722.55.1PUT0 3673.46TRUE00
2025-01-172510PUT0 8102.58TRUE00
2025-01-1727.58.11PUT0 14130.79TRUE00
2025-01-173012.8PUT0 0117.74TRUE00
2025-01-1732.50PUT0 0158.05TRUE00
2025-01-173521.6PUT0 0164.43TRUE00
2025-01-1737.524.7PUT0 0182.37TRUE00
2025-01-17400PUT0 0137.92TRUE00
2025-02-212.50CALL0 0239.05TRUE00
2025-02-2150CALL0 0141.65TRUE00
2025-02-217.50CALL0 042.6TRUE00
2025-02-21103CALL0 559.18TRUE00
2025-02-2112.51.8CALL0 892.2FALSE00
2025-02-21150CALL0 075.02FALSE00
2025-02-2117.50CALL0 00FALSE00
2025-02-21200CALL0 00FALSE00
2025-02-2122.50.9CALL0 10FALSE00
2025-02-212.50PUT0 00FALSE00
2025-02-2150PUT0 00FALSE00
2025-02-217.50PUT0 080.82FALSE00
2025-02-21100PUT0 061.46FALSE00
2025-02-2112.50PUT0 078.19TRUE00
2025-02-21150PUT0 075.36TRUE00
2025-02-2117.50PUT0 077.2TRUE00
2025-02-21200PUT0 082.43TRUE00
2025-02-2122.50PUT0 069TRUE00
2026-01-162.510.04CALL0 178.52TRUE00
2026-01-1650CALL0 090.01TRUE00
2026-01-167.55.97CALL0 368.06TRUE00
2026-01-16103.8CALL0 1467.85TRUE00
2026-01-1612.53.5CALL0 381.83FALSE00
2026-01-16152.65CALL0 290FALSE00
2026-01-1617.52.47CALL0 684.6FALSE00
2026-01-16201.66CALL0 15667.88FALSE00
2026-01-1622.51.5CALL0 5067.36FALSE00
2026-01-16251CALL3 2366.01FALSE10
2026-01-1627.51CALL0 270FALSE00
2026-01-16300.85CALL0 530FALSE00
2026-01-1632.51.02CALL0 170FALSE00
2026-01-16351CALL0 160FALSE00
2026-01-1637.50CALL0 00FALSE00
2026-01-16400.35CALL0 3280.75FALSE00
2026-01-162.50PUT0 00FALSE00
2026-01-1650PUT0 00FALSE00
2026-01-167.51.6PUT0 187.83FALSE00
2026-01-16102.8PUT0 166.83FALSE00
2026-01-1612.50PUT0 069.97TRUE00
2026-01-16156PUT0 4169.5TRUE00
2026-01-1617.53.7PUT0 474.98TRUE00
2026-01-16208PUT0 1368.39TRUE00
2026-01-1622.510.8PUT0 4086.93TRUE00
2026-01-162512PUT0 1071.27TRUE00
2026-01-1627.59PUT0 285.06TRUE00
2026-01-16300PUT0 090.15TRUE00
2026-01-1632.50PUT0 094.81TRUE00
2026-01-16350PUT0 092.04TRUE00
2026-01-1637.50PUT0 095.95TRUE00
2026-01-16400PUT0 0104.21TRUE00

Latest SAGE Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST10$32
Jun 13, 2022 7:59 PM EST7$31.98
Jun 13, 2022 7:59 PM EST37$31.98
Jun 13, 2022 7:59 PM EST100$31.98
Jun 13, 2022 7:59 PM EST1$31.99

Sage Therapeutics, Inc (SAGE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004431/0001562180-20-004431-index.htm
2020-07-23UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1597553/000000000020006722/0000000000-20-006722-index.htm
2020-09-01UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1597553/000000000020008250/0000000000-20-008250-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000008025519002669/0000080255-19-002669-index.htm
2020-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000008025520000011/0000080255-20-000011-index.htm
2020-04-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000008025520001438/0000080255-20-001438-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000021545719005781/0000215457-19-005781-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000031506619001342/0000315066-19-001342-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000031506620001221/0000315066-20-001221-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000083423720006703/0000834237-20-006703-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000089924319003668/0000899243-19-003668-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000093247119006113/0000932471-19-006113-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000110465920017946/0001104659-20-017946-index.htm
2018-12-18S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1597553/000119312518352130/0001193125-18-352130-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519003129/0001193125-19-003129-index.htm
2019-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519014879/0001193125-19-014879-index.htm
2019-02-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519043460/0001193125-19-043460-index.htm
2019-02-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1597553/000119312519043509/0001193125-19-043509-index.htm
2019-02-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1597553/000119312519049853/0001193125-19-049853-index.htm
2019-02-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1597553/000119312519052905/0001193125-19-052905-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519052913/0001193125-19-052913-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519053991/0001193125-19-053991-index.htm
2019-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519079860/0001193125-19-079860-index.htm
2019-04-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1597553/000119312519119608/0001193125-19-119608-index.htm
2019-04-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1597553/000119312519119616/0001193125-19-119616-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519133822/0001193125-19-133822-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519167248/0001193125-19-167248-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519173095/0001193125-19-173095-index.htm
2019-07-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519200528/0001193125-19-200528-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519213484/0001193125-19-213484-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519289188/0001193125-19-289188-index.htm
2019-12-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312519306717/0001193125-19-306717-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520050968/0001193125-20-050968-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1597553/000119312520051038/0001193125-20-051038-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520076535/0001193125-20-076535-index.htm
2020-04-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520100489/0001193125-20-100489-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1597553/000119312520124472/0001193125-20-124472-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1597553/000119312520124474/0001193125-20-124474-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520136314/0001193125-20-136314-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520165675/0001193125-20-165675-index.htm
2020-08-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1597553/000119312520208158/0001193125-20-208158-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520214068/0001193125-20-214068-index.htm
2020-08-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1597553/000119312520225608/0001193125-20-225608-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520261295/0001193125-20-261295-index.htm
2020-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520269896/0001193125-20-269896-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1597553/000119312520286184/0001193125-20-286184-index.htm
2018-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218018004912/0001562180-18-004912-index.htm
2018-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218018004913/0001562180-18-004913-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000187/0001562180-19-000187-index.htm
2019-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000252/0001562180-19-000252-index.htm
2019-01-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000487/0001562180-19-000487-index.htm
2019-01-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000488/0001562180-19-000488-index.htm
2019-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000489/0001562180-19-000489-index.htm
2019-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000490/0001562180-19-000490-index.htm
2019-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000492/0001562180-19-000492-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000858/0001562180-19-000858-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019000994/0001562180-19-000994-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001008/0001562180-19-001008-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001029/0001562180-19-001029-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001030/0001562180-19-001030-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001031/0001562180-19-001031-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001032/0001562180-19-001032-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001033/0001562180-19-001033-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001034/0001562180-19-001034-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001473/0001562180-19-001473-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001529/0001562180-19-001529-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001684/0001562180-19-001684-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001850/0001562180-19-001850-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019002013/0001562180-19-002013-index.htm
2019-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019002643/0001562180-19-002643-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019002767/0001562180-19-002767-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003095/0001562180-19-003095-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003388/0001562180-19-003388-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003389/0001562180-19-003389-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003390/0001562180-19-003390-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003391/0001562180-19-003391-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003392/0001562180-19-003392-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003393/0001562180-19-003393-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003394/0001562180-19-003394-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003395/0001562180-19-003395-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003636/0001562180-19-003636-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003637/0001562180-19-003637-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003638/0001562180-19-003638-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003639/0001562180-19-003639-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003640/0001562180-19-003640-index.htm
2019-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003968/0001562180-19-003968-index.htm
2019-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019003969/0001562180-19-003969-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004068/0001562180-19-004068-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004088/0001562180-19-004088-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004089/0001562180-19-004089-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004090/0001562180-19-004090-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004091/0001562180-19-004091-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004092/0001562180-19-004092-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004093/0001562180-19-004093-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004305/0001562180-19-004305-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004670/0001562180-19-004670-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019004788/0001562180-19-004788-index.htm
2019-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019005990/0001562180-19-005990-index.htm
2019-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019005991/0001562180-19-005991-index.htm
2019-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218019005993/0001562180-19-005993-index.htm
2020-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020000275/0001562180-20-000275-index.htm
2020-02-045Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020000855/0001562180-20-000855-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020001240/0001562180-20-001240-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020001242/0001562180-20-001242-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020001243/0001562180-20-001243-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020001244/0001562180-20-001244-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020001245/0001562180-20-001245-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020001246/0001562180-20-001246-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003221/0001562180-20-003221-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003222/0001562180-20-003222-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003223/0001562180-20-003223-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003224/0001562180-20-003224-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003225/0001562180-20-003225-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003226/0001562180-20-003226-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003263/0001562180-20-003263-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020003386/0001562180-20-003386-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004425/0001562180-20-004425-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004426/0001562180-20-004426-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004427/0001562180-20-004427-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004428/0001562180-20-004428-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004429/0001562180-20-004429-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004430/0001562180-20-004430-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020004431/0001562180-20-004431-index.htm
2020-10-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020006282/0001562180-20-006282-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1597553/000156218020006284/0001562180-20-006284-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1597553/000156223020000051/0001562230-20-000051-index.htm
2019-02-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1597553/000156459019003191/0001564590-19-003191-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1597553/000156459019015034/0001564590-19-015034-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1597553/000156459019028984/0001564590-19-028984-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1597553/000156459019042533/0001564590-19-042533-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1597553/000156459020007021/0001564590-20-007021-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1597553/000156459020022891/0001564590-20-022891-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1597553/000156459020038597/0001564590-20-038597-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1597553/000156459020050861/0001564590-20-050861-index.htm
2020-05-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1597553/999999999720003221/9999999997-20-003221-index.htm

Sage Therapeutics, Inc (SAGE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sage Therapeutics, Inc (SAGE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 161%
Institutional Ownership: 9380%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-02-12KEVIN P STARRDirectorSell0.000.00https://www.sec.gov/Archives/edgar/data/1597553/000089924319003668/0000899243-19-003668-index.htm
2019-05-10Anne Marie CookSVP, GC & SecretarySell15,000.00166.142,492,100.000.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002767/0001562180-19-002767-index.htm
2019-05-24JEFFREY M JONASPresident & CEOBuy40,356.000.4518,160.20102,471.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-12-09Albert RobichaudChief Scientific OfficerBuy6,935.001.369,431.60102,592.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019005991/0001562180-19-005991-index.htm
2019-07-17KIMI IGUCHICFO & TreasurerBuy4,000.001.365,440.0010,409.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003969/0001562180-19-003969-index.htm
2019-08-15JAMES M FRATESDirectorBuy8,000.0028.35226,800.0010,535.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004305/0001562180-19-004305-index.htm
2019-12-09Albert RobichaudChief Scientific OfficerBuy5,732.0038.25219,249.00108,324.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019005991/0001562180-19-005991-index.htm
2019-05-23JEFFREY M JONASPresident & CEOSell4,200.00173.41728,322.00109,704.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-02-15STEVEN M PAULDirectorSell12,519.00161.022,015,809.38111,385.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-12-09Albert RobichaudChief Scientific OfficerBuy3,076.0028.6388,065.88111,400.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019005991/0001562180-19-005991-index.htm
2019-05-23JEFFREY M JONASPresident & CEOSell1,619.00172.20278,791.80113,904.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-23JEFFREY M JONASPresident & CEOSell500.00171.0185,505.00115,523.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-23JEFFREY M JONASPresident & CEOBuy53,908.000.4524,258.60116,023.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-01-23JAMES M FRATESDirectorBuy7,500.008.9266,900.0011,735.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019000492/0001562180-19-000492-index.htm
2019-05-29JEFFREY M JONASPresident & CEOSell475.00171.3981,410.5412,115.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-05-06JAMES M FRATESDirectorBuy8,000.008.9271,360.0012,235.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002643/0001562180-19-002643-index.htm
2019-03-21STEVEN M PAULDirectorSell1,967.00161.02316,726.34122,400.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002013/0001562180-19-002013-index.htm
2019-07-25KIMI IGUCHICFO & TreasurerBuy2,000.001.362,720.0012,409.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004068/0001562180-19-004068-index.htm
2019-03-21STEVEN M PAULDirectorSell2,919.00161.05470,104.95124,367.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002013/0001562180-19-002013-index.htm
2019-05-29JEFFREY M JONASPresident & CEOSell400.00170.4068,158.0012,590.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-03-21STEVEN M PAULDirectorSell2,993.00161.04481,992.72127,286.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002013/0001562180-19-002013-index.htm
2019-05-29JEFFREY M JONASPresident & CEOSell200.00169.1633,832.0012,990.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-03-20STEVEN M PAULDirectorSell13,047.00161.352,105,133.45130,279.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-05-28JEFFREY M JONASPresident & CEOSell2,545.00177.62452,033.2313,190.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-12-09Albert RobichaudChief Scientific OfficerBuy25,000.0064.161,604,000.00136,400.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019005991/0001562180-19-005991-index.htm
2019-03-01KIMI IGUCHICFO & TreasurerSell25,563.00156.934,011,601.591,413.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001529/0001562180-19-001529-index.htm
2019-07-25KIMI IGUCHICFO & TreasurerBuy1,900.0014,309.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004089/0001562180-19-004089-index.htm
2019-03-20STEVEN M PAULDirectorSell13,096.00161.322,112,646.72143,326.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-05-10Anne Marie CookSVP, GC & SecretaryBuy15,000.0028.63429,450.0015,000.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002767/0001562180-19-002767-index.htm
2019-03-20STEVEN M PAULDirectorSell16,182.00161.202,608,538.40156,422.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-05-28JEFFREY M JONASPresident & CEOSell11,662.00176.442,057,673.6015,735.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-03-20STEVEN M PAULDirectorSell14,321.00161.322,310,263.72172,604.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-03-18STEVEN M PAULDirectorSell875.00161.01140,883.75186,925.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-03-18STEVEN M PAULDirectorSell800.00161.02128,816.00187,800.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-03-18STEVEN M PAULDirectorSell1,200.00161.14193,368.00188,600.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-03-18STEVEN M PAULDirectorSell900.00161.01144,909.00189,800.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001988/0001562180-19-001988-index.htm
2019-03-01STEVEN M PAULDirectorSell700.00161.00112,700.00190,700.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001684/0001562180-19-001684-index.htm
2019-03-01STEVEN M PAULDirectorSell700.00161.00112,700.00191,400.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001684/0001562180-19-001684-index.htm
2019-03-01STEVEN M PAULDirectorSell500.00161.0080,500.00192,100.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001684/0001562180-19-001684-index.htm
2019-03-01STEVEN M PAULDirectorSell700.00161.00112,700.00192,600.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001684/0001562180-19-001684-index.htm
2019-08-15JAMES M FRATESDirectorSell8,000.00160.581,284,640.002,535.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004305/0001562180-19-004305-index.htm
2019-05-22Michael CloonanChief Business OfficerBuy25,000.0073.431,835,750.0025,461.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003095/0001562180-19-003095-index.htm
2019-07-25Anne Marie CookSVP, GC & SecretaryBuy1,900.002,600.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004088/0001562180-19-004088-index.htm
2019-05-28JEFFREY M JONASPresident & CEOSell16,651.00175.722,925,880.4227,397.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-07-25Stephen KanesChief Medical OfficerBuy1,900.002,841.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004090/0001562180-19-004090-index.htm
2019-12-09KIMI IGUCHICFO & TreasurerBuy15,000.001.3620,400.0028,761.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019005993/0001562180-19-005993-index.htm
2019-12-10KIMI IGUCHICFO & TreasurerBuy500.001.36680.0029,261.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019005993/0001562180-19-005993-index.htm
2019-07-25Michael CloonanChief Business OfficerBuy2,450.003,190.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004093/0001562180-19-004093-index.htm
2020-04-30KIMI IGUCHICFO & TreasurerBuy4,000.001.365,440.0033,261.00https://www.sec.gov/Archives/edgar/data/1597553/000156218020003263/0001562180-20-003263-index.htm
2019-07-16JEFFREY M JONASPresident & CEOBuy27,000.000.4512,150.0039,115.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003968/0001562180-19-003968-index.htm
2019-01-23JAMES M FRATESDirectorSell7,500.00134.811,011,075.004,235.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019000492/0001562180-19-000492-index.htm
2019-05-06JAMES M FRATESDirectorSell8,000.00162.221,297,760.004,235.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002643/0001562180-19-002643-index.htm
2019-05-28JEFFREY M JONASPresident & CEOSell28,293.00174.484,936,667.3244,048.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-07-25JEFFREY M JONASPresident & CEOBuy5,000.0044,115.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004092/0001562180-19-004092-index.htm
2019-05-22Michael CloonanChief Business OfficerSell25,000.00175.004,375,000.00461.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003095/0001562180-19-003095-index.htm
2019-09-11JEFFREY M JONASPresident & CEOBuy4,600.000.452,070.0047,030.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004788/0001562180-19-004788-index.htm
2019-12-09JEFFREY M JONASPresident & CEOBuy7,500.0064.20481,500.0054,530.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019005990/0001562180-19-005990-index.htm
2019-03-08KIMI IGUCHICFO & TreasurerBuy4,723.000.452,125.356,136.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001850/0001562180-19-001850-index.htm
2019-01-09JEFFREY M JONASPresident & CEOBuy10,000.000.454,500.0062,115.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019000252/0001562180-19-000252-index.htm
2019-05-23JEFFREY M JONASPresident & CEOSell1,763.00176.15310,552.4562,115.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-24JEFFREY M JONASPresident & CEOSell950.00177.76168,872.0062,115.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-24JEFFREY M JONASPresident & CEOSell2,518.00176.80445,182.4063,065.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-23JEFFREY M JONASPresident & CEOSell14,727.00175.092,578,550.4363,878.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-24JEFFREY M JONASPresident & CEOSell3,974.00175.79698,589.4665,583.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-24JEFFREY M JONASPresident & CEOSell24,966.00175.024,369,549.3269,557.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-05-10Anne Marie CookSVP, GC & SecretaryBuy700.0056.2739,389.00700.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019002767/0001562180-19-002767-index.htm
2019-02-25STEVEN M PAULDirectorSell500.00161.0080,500.0070,900.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001473/0001562180-19-001473-index.htm
2019-02-25STEVEN M PAULDirectorSell500.00161.0080,500.0071,400.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001473/0001562180-19-001473-index.htm
2019-02-25STEVEN M PAULDirectorSell500.00161.0080,500.0071,900.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001473/0001562180-19-001473-index.htm
2019-05-28JEFFREY M JONASPresident & CEOSell25,510.00173.624,428,933.9672,341.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-02-25STEVEN M PAULDirectorSell500.00161.0080,500.0072,400.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001473/0001562180-19-001473-index.htm
2019-02-19STEVEN M PAULDirectorSell200.00162.0032,400.0072,900.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-02-19STEVEN M PAULDirectorSell643.00161.37103,760.9173,100.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-02-19STEVEN M PAULDirectorSell500.00161.6280,812.0073,743.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-02-19STEVEN M PAULDirectorSell200.00162.0032,400.0074,243.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-02-15STEVEN M PAULDirectorSell12,388.00161.021,994,715.7674,443.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-05-23JEFFREY M JONASPresident & CEOSell31,099.00174.465,425,531.5478,605.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-09-04Stephen KanesChief Medical OfficerBuy6,000.000.452,700.008,292.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004670/0001562180-19-004670-index.htm
2019-02-15STEVEN M PAULDirectorSell12,044.00161.021,939,324.8886,831.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm
2019-02-08Stephen KanesChief Medical OfficerSell22,948.00150.003,442,200.00941.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019000858/0001562180-19-000858-index.htm
2019-05-24JEFFREY M JONASPresident & CEOSell7,948.00174.051,383,349.4094,523.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003105/0001562180-19-003105-index.htm
2019-07-25Albert RobichaudChief Scientific OfficerBuy1,900.0096,205.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019004091/0001562180-19-004091-index.htm
2019-05-28JEFFREY M JONASPresident & CEOBuy35,736.000.4516,081.2097,851.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019003161/0001562180-19-003161-index.htm
2019-02-15STEVEN M PAULDirectorSell12,510.00161.022,014,360.2098,875.00https://www.sec.gov/Archives/edgar/data/1597553/000156218019001080/0001562180-19-001080-index.htm